Variant report

Variant	nsv998769
Chromosome Location	chr4:48989185-49083089
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:348)
CpG islands
(count:122)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:348 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr4:49034389-49034885	A549	lung:	n/a	chr4:49034607-49034618
2	CEBPB	chr4:49020888-49021038	IMR90	lung:	n/a	chr4:49020962-49020973
3	CEBPB	chr4:49034434-49034808	Hela-S3	cervix:	n/a	chr4:49034607-49034618
4	CEBPB	chr4:49034494-49034836	ECC-1	luminal epithelium:	n/a	chr4:49034607-49034618
5	CEBPB	chr4:49034470-49034787	HepG2	liver:	n/a	chr4:49034607-49034618
6	CEBPB	chr4:49034404-49034777	K562	blood:	n/a	chr4:49034607-49034618
7	CEBPB	chr4:49020904-49021000	A549	lung:	n/a	chr4:49020962-49020973
8	CEBPB	chr4:49034451-49034802	A549	lung:	n/a	chr4:49034607-49034618
9	CEBPB	chr4:49020953-49021002	K562	blood:	n/a	chr4:49020962-49020973
10	CEBPB	chr4:49082946-49082952	K562	blood:	n/a	n/a
11	CEBPB	chr4:49034541-49034701	A549	lung:	n/a	chr4:49034607-49034618
12	CEBPB	chr4:49034427-49034820	MCF-7	breast:	n/a	chr4:49034607-49034618
13	CEBPB	chr4:49034476-49034725	K562	blood:	n/a	chr4:49034607-49034618
14	CEBPB	chr4:49034479-49034768	ECC-1	luminal epithelium:	n/a	chr4:49034607-49034618
15	CEBPB	chr4:49034477-49034777	IMR90	lung:	n/a	chr4:49034607-49034618
16	CEBPB	chr4:49082855-49083049	IMR90	lung:	n/a	chr4:49082942-49082951 chr4:49082940-49082951 chr4:49082942-49082953
17	CEBPB	chr4:49034546-49034709	HepG2	liver:	n/a	chr4:49034607-49034618
18	CEBPB	chr4:49034505-49034753	HepG2	liver:	n/a	chr4:49034607-49034618
19	CEBPB	chr4:49082949-49082960	A549	lung:	n/a	n/a
20	CEBPB	chr4:49034566-49034711	H1-hESC	embryonic stem cell:	n/a	chr4:49034607-49034618
21	CEBPB	chr4:49046392-49046617	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr4:49082827-49083064	HepG2	liver:	n/a	chr4:49083044-49083055 chr4:49083042-49083055 chr4:49082942-49082951 chr4:49082940-49082951 chr4:49082942-49082953
23	CEBPB	chr4:49020826-49021092	HepG2	liver:	n/a	chr4:49020962-49020973
24	CEBPB	chr4:49034387-49034825	MCF-7	breast:	n/a	chr4:49034607-49034618
25	CEBPB	chr4:49034435-49034795	K562	blood:	n/a	chr4:49034607-49034618
26	CEBPB	chr4:49034462-49034774	HepG2	liver:	n/a	chr4:49034607-49034618
27	CEBPB	chr4:49045200-49045225	HepG2	liver:	n/a	chr4:49045204-49045215
28	CEBPD	chr4:49034505-49034705	HepG2	liver:	n/a	chr4:49034606-49034617
29	CTCF	chr4:49034509-49034776	GM12878	blood:	n/a	n/a
30	CTCF	chr4:49034496-49034782	LNCaP	prostate:	n/a	n/a
31	CTCF	chr4:49072380-49072453	Kidney_OC	kidney:	n/a	n/a
32	CTCF	chr4:48994380-48994530	HVMF	connective:	n/a	n/a
33	CTCF	chr4:49034529-49034782	GM12892	blood:	n/a	n/a
34	CTCF	chr4:49034507-49034775	K562	blood:	n/a	n/a
35	CTCF	chr4:49030620-49030770	HEEpiC	esophagus:	n/a	n/a
36	CTCF	chr4:49034535-49034761	ECC-1	luminal epithelium:	n/a	n/a
37	CTCF	chr4:49034580-49034730	HCPEpiC	choroid plexus:	n/a	n/a
38	CTCF	chr4:49034540-49034690	RPTEC	kidney:	n/a	n/a
39	CTCF	chr4:49030660-49030810	RPTEC	kidney:	n/a	n/a
40	CTCF	chr4:49034531-49034768	GM19239	blood:	n/a	n/a
41	CTCF	chr4:49034462-49034839	GM12878	blood:	n/a	n/a
42	CTCF	chr4:49034560-49034710	HPAF	blood vessel:	n/a	n/a
43	CTCF	chr4:49034600-49034750	AG09309	skin:	n/a	n/a
44	CTCF	chr4:49070079-49070110	GM10266	blood:	n/a	n/a
45	CTCF	chr4:49034532-49034740	GM10248	blood:	n/a	n/a
46	CTCF	chr4:49030648-49030696	Kidney_OC	kidney:	n/a	n/a
47	CTCF	chr4:49034600-49034750	Hela-S3	cervix:	n/a	n/a
48	CTCF	chr4:49034935-49034978	Gliobla	brain:	n/a	n/a
49	CTCF	chr4:49034560-49034710	AG10803	skin:	n/a	n/a
50	CTCF	chr4:49034560-49034710	HFF	foreskin:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:48990530-48990580	HEK293	kidney:	embryo
2	chr4:48990530-48990580	NHDF-neo	bronchial:	n/a
3	chr4:48990530-48990580	PFSK-1	brain:	n/a
4	chr4:48991973-48992023	AoSMC	blood vessel:	n/a
5	chr4:48991973-48992023	Hepatocyte	liver:	n/a
6	chr4:48990530-48990580	AG09309	skin:	n/a
7	chr4:48991973-48992023	Jurkat	blood:	n/a
8	chr4:48991973-48992023	SAEC	small airway:	n/a
9	chr4:48991973-48992023	BJ	skin:	n/a
10	chr4:48990530-48990580	HCM	heart:	n/a
11	chr4:48991973-48992023	NB4	blood:	n/a
12	chr4:48991973-48992023	HEEpiC	esophagus:	n/a
13	chr4:48990530-48990580	SAEC	small airway:	n/a
14	chr4:48991973-48992023	AG04449	skin:	fetal
15	chr4:48990530-48990580	HMEC	breast:	n/a
16	chr4:48990530-48990580	GM06990	blood:	n/a
17	chr4:48990530-48990580	HEEpiC	esophagus:	n/a
18	chr4:48990530-48990580	AoSMC	blood vessel:	n/a
19	chr4:48990530-48990580	HIPEpiC	eye:	n/a
20	chr4:48990530-48990580	SK-N-SH_RA	brain:	n/a
21	chr4:48991973-48992023	Hela-S3	cervix:	n/a
22	chr4:48991973-48992023	HRCEpiC	kidney:	n/a
23	chr4:48990530-48990580	H1-hESC	embryonic stem cell:	embryo
24	chr4:48991973-48992023	GM06990	blood:	n/a
25	chr4:48991973-48992023	PrEC	prostate:	n/a
26	chr4:48991973-48992023	HCPEpiC	choroid plexus:	n/a
27	chr4:48991973-48992023	HRE	kidney:	n/a
28	chr4:48991973-48992023	LNCaP	prostate:	n/a
29	chr4:48990530-48990580	MCF10A-Er-Src	breast:	n/a
30	chr4:48991973-48992023	CMK	blood:	n/a
31	chr4:48990530-48990580	IMR90	lung:	fetal
32	chr4:48991973-48992023	HIPEpiC	eye:	n/a
33	chr4:48991973-48992023	GM19239	blood:	n/a
34	chr4:48991973-48992023	PANC-1	pancreas:	n/a
35	chr4:48990530-48990580	HRE	kidney:	n/a
36	chr4:48990530-48990580	PANC-1	pancreas:	n/a
37	chr4:48990530-48990580	HCT-116	colon:	n/a
38	chr4:48990530-48990580	GM12891	blood:	n/a
39	chr4:48990530-48990580	NT2-D1	testis:	n/a
40	chr4:48990530-48990580	HNPCEpiC	eye:	n/a
41	chr4:48990530-48990580	AG04449	skin:	fetal
42	chr4:48990530-48990580	AG04450	lung:	fetal
43	chr4:48991973-48992023	AG10803	skin:	n/a
44	chr4:48990530-48990580	AG09319	gingival:	n/a
45	chr4:48991973-48992023	IMR90	lung:	fetal
46	chr4:48991973-48992023	SKMC	muscle:	n/a
47	chr4:48990530-48990580	HPAEpiC	pulmonary alveolar:	n/a
48	chr4:48990530-48990580	CMK	blood:	n/a
49	chr4:48991973-48992023	PFSK-1	brain:	n/a
50	chr4:48990530-48990580	SK-N-MC	brain:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:48993956..48996256-chr4:49000276..49001827,2	K562	blood:
2	chr4:48993956..48996256-chr4:49000276..49001827,2	K562	blood:
3	chr4:48987005..48989182-chr4:48992277..48994580,2	K562	blood:
4	chr4:48998219..48999902-chr4:49007449..49009207,2	K562	blood:
5	chr4:49061609..49064062-chr4:49065907..49068777,2	K562	blood:
6	chr4:48965085..48965843-chr4:49034216..49034787,2	MCF-7	breast:
7	chr4:49061609..49064062-chr4:49065907..49068777,2	K562	blood:
8	chr1:55352442..55353197-chr4:49034365..49034935,2	MCF-7	breast:
9	chr4:48998219..48999902-chr4:49007449..49009207,2	K562	blood:

No data

Variant related genes	Relation type
TPI1P4	TF binding region
CWH43	TF binding region
TPI1P4	CpG island
CWH43	CpG island
ENSG00000109182	chromatin interactions
ENSG00000242396	chromatin interactions
ENSG00000116133	chromatin interactions

Extended variants
information (count: 2951 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:2951 , 50 per page) page: 1 2 3 4 5 6 7 ... 60

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs372714417	chr4:48989227-48989228	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs551223181	chr4:48989231-48989232	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs571551798	chr4:48989245-48989246	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs4695413	chr4:48989261-48989262	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs182673896	chr4:48989267-48989268	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs187354117	chr4:48989284-48989285	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs193155717	chr4:48989328-48989329	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs4695414	chr4:48989358-48989359	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs548183237	chr4:48989381-48989382	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs558656304	chr4:48989382-48989383	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs577200908	chr4:48989403-48989404	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs142852533	chr4:48989436-48989437	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs555995415	chr4:48989456-48989457	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs574272760	chr4:48989559-48989560	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs574404367	chr4:48989561-48989562	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs73246060	chr4:48989608-48989609	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs559962144	chr4:48989637-48989638	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs80071668	chr4:48989724-48989725	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs545918810	chr4:48989745-48989746	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs146571061	chr4:48989765-48989766	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs189106378	chr4:48989770-48989771	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs140043046	chr4:48989774-48989775	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs561113703	chr4:48989844-48989845	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs563134403	chr4:48989849-48989850	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs530458133	chr4:48989850-48989851	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs143579086	chr4:48989854-48989855	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs556626192	chr4:48989884-48989885	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs534018911	chr4:48990017-48990018	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs192204141	chr4:48990060-48990061	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs200279281	chr4:48990101-48990102	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs375043967	chr4:48990182-48990183	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs570862069	chr4:48990204-48990205	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs115305316	chr4:48990239-48990240	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs146901899	chr4:48990308-48990309	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs574391483	chr4:48990309-48990310	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs535389396	chr4:48990319-48990320	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs553535946	chr4:48990329-48990330	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs572172477	chr4:48990387-48990388	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs545702480	chr4:48990401-48990402	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs532154605	chr4:48990405-48990406	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs564160870	chr4:48990421-48990422	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs550261817	chr4:48990438-48990439	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs576063779	chr4:48990476-48990477	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs543432466	chr4:48990477-48990478	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs558857432	chr4:48990478-48990479	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs373205177	chr4:48990490-48990491	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs138804221	chr4:48990498-48990499	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs138006472	chr4:48990529-48990530	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs370635335	chr4:48990530-48990531	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs141376548	chr4:48990552-48990553	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
Oral squamous cell carcinoma	17134496	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Cancer	22183965	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	21399695	CNVD
Breast cancer	16272173	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:141 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:48987600-48989200	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
2	chr4:48987600-48989200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
3	chr4:48987800-48989800	Active TSS	Rectal Smooth Muscle	rectum
4	chr4:48988000-48989200	Active TSS	Rectal Mucosa Donor 29	rectum
5	chr4:48988200-48989200	Bivalent/Poised TSS	NHEK	skin
6	chr4:48988200-48990000	Active TSS	Colonic Mucosa	Colon
7	chr4:48988600-49000400	Weak transcription	Gastric	stomach
8	chr4:48989000-48990200	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
9	chr4:48989000-48990200	Enhancers	Stomach Mucosa	stomach
10	chr4:48989000-48993400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr4:48989000-49000400	Weak transcription	Esophagus	oesophagus
12	chr4:48989200-48989600	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
13	chr4:48989200-48990000	Active TSS	NHEK	skin
14	chr4:48989200-48990600	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
15	chr4:48989600-48990000	Active TSS	Rectal Mucosa Donor 29	rectum
16	chr4:48990000-48990200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
17	chr4:48990000-48993000	Weak transcription	NHEK	skin
18	chr4:48990200-48990600	Weak transcription	Stomach Mucosa	stomach
19	chr4:48990200-48991200	Weak transcription	Rectal Mucosa Donor 31	rectum
20	chr4:48990200-48991400	Enhancers	Rectal Mucosa Donor 29	rectum
21	chr4:48990600-48991400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
22	chr4:48990600-48992800	Enhancers	Stomach Mucosa	stomach
23	chr4:48990800-48991800	Enhancers	Sigmoid Colon	Sigmoid Colon
24	chr4:48991200-48994000	Enhancers	Rectal Mucosa Donor 31	rectum
25	chr4:48991400-48991600	Bivalent Enhancer	Aorta	Aorta
26	chr4:48991400-48992800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
27	chr4:48991400-49018400	Weak transcription	Rectal Mucosa Donor 29	rectum
28	chr4:48991800-48993000	Weak transcription	Sigmoid Colon	Sigmoid Colon
29	chr4:48992800-48993000	Genic enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr4:48993000-48993400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr4:48993000-48993600	Enhancers	Sigmoid Colon	Sigmoid Colon
32	chr4:48993000-48993800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
33	chr4:48993000-48995200	Enhancers	NHEK	skin
34	chr4:48993400-48993600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr4:48993400-48993600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr4:48993600-48994000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
37	chr4:48993600-48994800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr4:48993600-49017400	Weak transcription	Sigmoid Colon	Sigmoid Colon
39	chr4:48994000-48994800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
40	chr4:48994000-48996800	Weak transcription	Rectal Mucosa Donor 31	rectum
41	chr4:48994400-48995400	Enhancers	Stomach Smooth Muscle	stomach
42	chr4:48994800-48995400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr4:48994800-48995600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
44	chr4:48994800-48995600	Enhancers	Hela-S3	cervix
45	chr4:48995400-48995600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
46	chr4:48995600-48996000	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr4:48996000-48996200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr4:48996200-48997200	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr4:48996800-48997200	Strong transcription	Rectal Mucosa Donor 31	rectum
50	chr4:48997200-49000400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links